WHO ICTRP trial

To test the cosmetic safety by assessing the skin irritation and allergic…

CTRI/2022/01/039387 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2022/01/039387
Public title To test the cosmetic safety by assessing the skin irritation and allergic potential by using repeated patch test in healthy male and female human adult subjects
Scientific title Repeated patch test (HRIPT) to examine the potential for cutaneous irritancy and allergic sensitization of Baby Cosmetic products marketed by Vishal Mega Mart Pvt. Ltd., under complete occlusion on healthy male and female human subjects.
Primary sponsor Vishal Mega Mart Pvt Ltd
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Countries India
Interventions Intervention1: Yellow Hippo Baby Cream: Patch will be applied on thrice a week basis for three weeks. The patch is removed after 24 hrs of contact each timed clinical examination is carried out 24 hr after patch removal. Intervention2…
Registration date Jan 13, 2022
Target size 24
Secondary IDs IDMA/HRIPT/2021/03
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations